Pathways | p Value |
---|---|
Cdc42 signalling | 0.00002 |
Crosstalk between dendritic cells and natural killer cells | 0.00015 |
Graft-versus-host disease signalling | 0.00069 |
OX40 signalling pathway | 0.00151 |
Antigen presentation pathway | 0.00468 |
Neuroprotective role of THOP1 in Alzheimer’s disease | 0.00589 |
Taurine and hypotaurine metabolism | 0.00617 |
Autoimmune thyroid disease signalling | 0.00661 |
Regulation of actin-based motility by Rho | 0.00676 |
Communication between innate and adaptive immune cells | 0.00676 |
Aryl hydrocarbon receptor signalling | 0.00759 |
Integrin signalling | 0.00891 |
Allograft rejection signalling | 0.00977 |
Cytotoxic T-lymphocyte-mediated apoptosis of target cells | 0.01023 |
Cyanoamino acid metabolism | 0.01047 |
Glutathione metabolism | 0.01072 |
Amyotrophic lateral sclerosis signalling | 0.01230 |
Systemic lupus erythematosus signalling | 0.01230 |
PXR/RXR activation | 0.01995 |
Macropinocytosis signalling | 0.02455 |
Selenoamino acid metabolism | 0.02692 |
Xenobiotic metabolism signalling | 0.02951 |
Cellular effects of sildenafil (Viagra) | 0.03162 |
Aminoacyl-tRNA biosynthesis | 0.03631 |
Actin cytoskeleton signalling | 0.04365 |
FAK signalling | 0.04467 |
Apoptosis signalling | 0.04677 |
Pathways discussed in the text are given in italic.